Role of renal vascular coordinator on access flow dysfunction: A quality improvement initiative on improving patency rate.

IF 1.6 3区 医学 Q3 PERIPHERAL VASCULAR DISEASE Journal of Vascular Access Pub Date : 2025-02-04 DOI:10.1177/11297298251316953
Mary Lim Zhi Ting, Cathrine Kong May Ching, Chai Chung Cheen, Allen Liu Yan Lun
{"title":"Role of renal vascular coordinator on access flow dysfunction: A quality improvement initiative on improving patency rate.","authors":"Mary Lim Zhi Ting, Cathrine Kong May Ching, Chai Chung Cheen, Allen Liu Yan Lun","doi":"10.1177/11297298251316953","DOIUrl":null,"url":null,"abstract":"<p><p>A renal vascular coordinator (RVC) is a single point-of-contact allied health professional in the early detection and timely intervention of flow dysfunction. In Khoo Teck Puat Hospital (KTPH), RVC performs access ultrasonography assessment and assists in reviewing direct referrals about dysfunctional arteriovenous fistula (AVF)/arteriovenous graft (AVG) from community dialysis centres and plans for appointments with interventional nephrologists and vascular surgeons. We conducted a prospective study from April 2020 to December 2022 to evaluate the appointment-to-intervention time (AIT) and patency rate (PR) of vascular access interventions. Secondary outcome was the percentage of vascular access loss. Ninety-three patients were referred to the RVC and were offered thrombectomy or angioplasty. Twenty-seven patients were excluded from the analysis (did not require intervention (9), admitted without RVC assessment (13), defaulted (4), or bypassed an RVC appointment to their first intervention (1)). The median time from referral to their first RVC visit was 4 (3-6) days. The median AIT for the RVC group was 6 (3-11) days (21.5% within 48 h). The median AIT for the non-RVC group was 6 (2.3-12.8) days (25.5% within 48 h, <i>p</i> = 1.0). The 6-month and 12-month post-intervention PR was 71% and 61.3%, respectively. Fifty-one of the remaining ninety-three patients had previous procedures done to their AVF before April 2020 without RVC involvement. The 6-month and 12-month post-intervention PR was 51% (<i>p</i> < 0.016) and 15.7% (<i>p</i> < 0.00001), respectively. The percentage of vascular access loss was similar in both RVC and non-RVC groups (4.3% vs 2%, <i>p</i> = 0.44). With the addition of RVC, vascular access outcome is improved with longer PR for up to 12 months, with no difference in AIT and number of vascular access losses.</p>","PeriodicalId":56113,"journal":{"name":"Journal of Vascular Access","volume":" ","pages":"11297298251316953"},"PeriodicalIF":1.6000,"publicationDate":"2025-02-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Vascular Access","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/11297298251316953","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PERIPHERAL VASCULAR DISEASE","Score":null,"Total":0}
引用次数: 0

Abstract

A renal vascular coordinator (RVC) is a single point-of-contact allied health professional in the early detection and timely intervention of flow dysfunction. In Khoo Teck Puat Hospital (KTPH), RVC performs access ultrasonography assessment and assists in reviewing direct referrals about dysfunctional arteriovenous fistula (AVF)/arteriovenous graft (AVG) from community dialysis centres and plans for appointments with interventional nephrologists and vascular surgeons. We conducted a prospective study from April 2020 to December 2022 to evaluate the appointment-to-intervention time (AIT) and patency rate (PR) of vascular access interventions. Secondary outcome was the percentage of vascular access loss. Ninety-three patients were referred to the RVC and were offered thrombectomy or angioplasty. Twenty-seven patients were excluded from the analysis (did not require intervention (9), admitted without RVC assessment (13), defaulted (4), or bypassed an RVC appointment to their first intervention (1)). The median time from referral to their first RVC visit was 4 (3-6) days. The median AIT for the RVC group was 6 (3-11) days (21.5% within 48 h). The median AIT for the non-RVC group was 6 (2.3-12.8) days (25.5% within 48 h, p = 1.0). The 6-month and 12-month post-intervention PR was 71% and 61.3%, respectively. Fifty-one of the remaining ninety-three patients had previous procedures done to their AVF before April 2020 without RVC involvement. The 6-month and 12-month post-intervention PR was 51% (p < 0.016) and 15.7% (p < 0.00001), respectively. The percentage of vascular access loss was similar in both RVC and non-RVC groups (4.3% vs 2%, p = 0.44). With the addition of RVC, vascular access outcome is improved with longer PR for up to 12 months, with no difference in AIT and number of vascular access losses.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
肾血管协调员在通路血流功能障碍中的作用:提高通畅率的质量改进措施。
肾血管协调员(RVC)是一名单点联系的专职医疗专业人员,负责早期发现和及时干预血流功能障碍。在邱德拔医院(Khoo Teck Puat Hospital,KTPH),肾血管协调员负责通路超声波评估,协助审查社区透析中心直接转来的动静脉瘘(AVF)/动静脉移植(AVG)功能障碍患者,并计划预约介入肾病学家和血管外科医生。我们在 2020 年 4 月至 2022 年 12 月期间开展了一项前瞻性研究,以评估血管通路介入治疗的预约到介入时间 (AIT) 和通畅率 (PR)。次要结果是血管通路损失的百分比。93名患者被转诊至RVC,并接受了血栓切除术或血管成形术。分析中排除了 27 例患者(不需要介入治疗(9 例)、入院时未接受 RVC 评估(13 例)、违约(4 例)或绕过 RVC 预约进行首次介入治疗(1 例))。从转诊到首次接受 RVC 检查的中位时间为 4 (3-6) 天。RVC 组的 AIT 中位数为 6(3-11)天(21.5% 在 48 小时内)。非 RVC 组的 AIT 中位数为 6 (2.3-12.8) 天(25.5% 在 48 小时内,p = 1.0)。干预后 6 个月和 12 个月的 PR 分别为 71% 和 61.3%。其余 93 名患者中,有 51 人曾在 2020 年 4 月前对其动静脉瘘进行过手术,但未涉及 RVC。干预后 6 个月和 12 个月的 PR 为 51%(p p = 0.44)。加入 RVC 后,血管通路结果得到改善,PR 长达 12 个月,AIT 和血管通路损失次数没有差异。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of Vascular Access
Journal of Vascular Access 医学-外周血管病
CiteScore
3.40
自引率
31.60%
发文量
181
审稿时长
6-12 weeks
期刊介绍: The Journal of Vascular Access (JVA) is issued six times per year; it considers the publication of original manuscripts dealing with clinical and laboratory investigations in the fast growing field of vascular access. In addition reviews, case reports and clinical trials are welcome, as well as papers dedicated to more practical aspects covering new devices and techniques. All contributions, coming from all over the world, undergo the peer-review process. The Journal of Vascular Access is divided into independent sections, each led by Editors of the highest scientific level: • Dialysis • Oncology • Interventional radiology • Nutrition • Nursing • Intensive care Correspondence related to published papers is also welcome.
期刊最新文献
Retraction: Novel electrospun polyurethane grafts for vascular access in rats. Feasibility and Safety of bedside placement of tunneled dialysis catheters: A systematic review and meta-analysis of prevalence. Retained foreign body in radial artery: Endovascular retrieval and salvage of a hemodialysis arteriovenous fistula. Role of renal vascular coordinator on access flow dysfunction: A quality improvement initiative on improving patency rate. Ultrasound and fluoroscopy co-guided removal of extravascular stripped central line guidewire fragments.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1